Armis Advisers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$333K Buy
3,627
+1,135
+46% +$100K 0.03% 356
2026
Q2
$207K Buy
+2,492
New +$201K 0.02% 464
2026
Q1
– Sell
-3,093
Closed -$266K – 470
2025
Q4
$266K Buy
3,093
+100
+3% +$9.7K 0.03% 351
2025
Q3
$270K Sell
2,993
-42
-1% -$3.86K 0.02% 269
2025
Q2
$273K Buy
+3,035
New +$257K 0.02% 385

Other funds holding MDT

Armis Advisers's MDT Position: Q3 2026 in Review

Armis Advisers increased its Medtronic (MDT) stake by 46% in Q3 2026, buying an estimated $100K and bringing the position to 3,627 shares worth $333K. The position accounts for 0.03% of the portfolio, ranked #356.

Armis Advisers first reported a position in MDT in Q2 2025 and has held it in 5 quarters since. 757 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Armis Advisers held 3,627 shares of Medtronic worth $333K as of Q3 2026.
  • Armis Advisers bought 1,135 Medtronic shares in Q3 2026, an estimated $100K.
  • Medtronic made up 0.03% of Armis Advisers's portfolio in Q3 2026, its #356 holding.
  • Armis Advisers first reported a position in Medtronic in Q2 2025 and has held it in 5 quarters since.
  • 757 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Armis Advisers's 13F filing for Q3 2026, filed 13 Oct 2026.